Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress
13.10.2021 - Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that it will present new preclinical data at the ... Seite 1
United States Laura Lombardi Tenaya Therapeutics Inc European Society Of Gene University Of Texas Southwestern Medical Center Gene Transfer Prevents Development Of Arrhythmogenic Cardiomyopathy
Source: wallstreet-online.de